Clinical efficacy and safety of Shensong Yangxin capsule-antiarrhythmic drug combination for paroxysmal atrial fibrillation: A meta-analysis of randomized controlled trials

Authors
Category Systematic review
JournalEUROPEAN JOURNAL OF INTEGRATIVE MEDICINE
Year 2024
This article has no abstract
Epistemonikos ID: b0981dbbf467877d9b4956fadf3ad9e0c1b856a6
First added on: Feb 16, 2025